

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.11763978 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.24428026 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.24428026 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.14907392 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.92478447 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.92478447 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.92478447 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.92478447 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.92478447 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.92478447 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.73454817 |
| 12 | cellular extravasation (GO:0045123) | 4.68955717 |
| 13 | microglial cell activation (GO:0001774) | 4.59102887 |
| 14 | detection of molecule of bacterial origin (GO:0032490) | 4.56891289 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.55108216 |
| 16 | response to peptidoglycan (GO:0032494) | 4.45079750 |
| 17 | detection of other organism (GO:0098543) | 4.41188800 |
| 18 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.40514816 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.32941854 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.30875533 |
| 21 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.30707187 |
| 22 | neutrophil mediated immunity (GO:0002446) | 4.03559734 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 4.02203941 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.01534723 |
| 25 | detection of external biotic stimulus (GO:0098581) | 3.98614673 |
| 26 | detection of bacterium (GO:0016045) | 3.94473652 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.86223078 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.85964588 |
| 29 | response to muramyl dipeptide (GO:0032495) | 3.83828239 |
| 30 | macrophage activation (GO:0042116) | 3.83085335 |
| 31 | L-phenylalanine catabolic process (GO:0006559) | 3.80877430 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.80877430 |
| 33 | urea cycle (GO:0000050) | 3.79597346 |
| 34 | urea metabolic process (GO:0019627) | 3.79597346 |
| 35 | kynurenine metabolic process (GO:0070189) | 3.78342445 |
| 36 | aromatic amino acid family catabolic process (GO:0009074) | 3.76672279 |
| 37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.76180069 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 3.74239489 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 3.72401669 |
| 40 | indolalkylamine catabolic process (GO:0046218) | 3.72401669 |
| 41 | tryptophan catabolic process (GO:0006569) | 3.72401669 |
| 42 | B cell receptor signaling pathway (GO:0050853) | 3.72131555 |
| 43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.71366170 |
| 44 | detection of biotic stimulus (GO:0009595) | 3.64996380 |
| 45 | neutrophil activation (GO:0042119) | 3.62227933 |
| 46 | positive regulation of mast cell activation (GO:0033005) | 3.60359604 |
| 47 | regulation of protein activation cascade (GO:2000257) | 3.59658329 |
| 48 | bile acid biosynthetic process (GO:0006699) | 3.59173021 |
| 49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.57501136 |
| 50 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.56773457 |
| 51 | negative thymic T cell selection (GO:0045060) | 3.54503709 |
| 52 | complement activation, alternative pathway (GO:0006957) | 3.52439599 |
| 53 | negative T cell selection (GO:0043383) | 3.51445287 |
| 54 | positive regulation of B cell differentiation (GO:0045579) | 3.50759448 |
| 55 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.50468172 |
| 56 | leukocyte aggregation (GO:0070486) | 3.49262704 |
| 57 | cysteine metabolic process (GO:0006534) | 3.47871387 |
| 58 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.47481079 |
| 59 | L-phenylalanine metabolic process (GO:0006558) | 3.47481079 |
| 60 | myeloid leukocyte mediated immunity (GO:0002444) | 3.46691725 |
| 61 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.43551467 |
| 62 | nitrogen cycle metabolic process (GO:0071941) | 3.43488608 |
| 63 | tryptophan metabolic process (GO:0006568) | 3.42886344 |
| 64 | response to host immune response (GO:0052572) | 3.42440050 |
| 65 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.42440050 |
| 66 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.42259862 |
| 67 | regulation of complement activation (GO:0030449) | 3.40762150 |
| 68 | regulation of triglyceride catabolic process (GO:0010896) | 3.40210313 |
| 69 | immunoglobulin mediated immune response (GO:0016064) | 3.40192031 |
| 70 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.39403253 |
| 71 | activated T cell proliferation (GO:0050798) | 3.38838627 |
| 72 | alpha-linolenic acid metabolic process (GO:0036109) | 3.37581490 |
| 73 | myeloid cell activation involved in immune response (GO:0002275) | 3.33740697 |
| 74 | regulation of tolerance induction (GO:0002643) | 3.32050642 |
| 75 | positive thymic T cell selection (GO:0045059) | 3.30102898 |
| 76 | amino-acid betaine metabolic process (GO:0006577) | 3.29345328 |
| 77 | granulocyte activation (GO:0036230) | 3.28126975 |
| 78 | serine family amino acid catabolic process (GO:0009071) | 3.27926665 |
| 79 | regulation of mast cell activation (GO:0033003) | 3.27562970 |
| 80 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.27291760 |
| 81 | high-density lipoprotein particle remodeling (GO:0034375) | 3.27287674 |
| 82 | regulation of B cell differentiation (GO:0045577) | 3.27153438 |
| 83 | tolerance induction (GO:0002507) | 3.25602222 |
| 84 | positive regulation of granulocyte differentiation (GO:0030854) | 3.25598130 |
| 85 | protein carboxylation (GO:0018214) | 3.25352864 |
| 86 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.25352864 |
| 87 | cellular ketone body metabolic process (GO:0046950) | 3.25293336 |
| 88 | positive T cell selection (GO:0043368) | 3.24925220 |
| 89 | fatty acid transmembrane transport (GO:1902001) | 3.23342268 |
| 90 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.19716362 |
| 91 | response to host (GO:0075136) | 3.19716362 |
| 92 | response to host defenses (GO:0052200) | 3.19716362 |
| 93 | respiratory burst (GO:0045730) | 3.19476351 |
| 94 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.16480529 |
| 95 | regulation of mast cell degranulation (GO:0043304) | 3.15650650 |
| 96 | phospholipid homeostasis (GO:0055091) | 3.14502251 |
| 97 | germinal center formation (GO:0002467) | 3.14300693 |
| 98 | T cell migration (GO:0072678) | 3.12114033 |
| 99 | response to interleukin-15 (GO:0070672) | 3.12108097 |
| 100 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11826191 |
| 101 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.11507854 |
| 102 | glutamate metabolic process (GO:0006536) | 3.10477498 |
| 103 | carnitine shuttle (GO:0006853) | 3.10324474 |
| 104 | vitamin transmembrane transport (GO:0035461) | 3.10000770 |
| 105 | defense response to protozoan (GO:0042832) | 3.07362870 |
| 106 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.07360314 |
| 107 | regulation of fibrinolysis (GO:0051917) | 3.07159033 |
| 108 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.06423551 |
| 109 | regulation of T cell tolerance induction (GO:0002664) | 3.04887079 |
| 110 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.04324060 |
| 111 | reverse cholesterol transport (GO:0043691) | 3.02868491 |
| 112 | lysine metabolic process (GO:0006553) | 3.02714253 |
| 113 | lysine catabolic process (GO:0006554) | 3.02714253 |
| 114 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.02710712 |
| 115 | positive regulation of lipid catabolic process (GO:0050996) | 3.01730750 |
| 116 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.00812501 |
| 117 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.99896832 |
| 118 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.99370517 |
| 119 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.99370517 |
| 120 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.99366743 |
| 121 | lymph vessel development (GO:0001945) | 2.99083632 |
| 122 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.98454202 |
| 123 | positive regulation of mast cell degranulation (GO:0043306) | 2.98454202 |
| 124 | negative regulation of adaptive immune response (GO:0002820) | 2.98238656 |
| 125 | phospholipid efflux (GO:0033700) | 2.97565358 |
| 126 | glyoxylate metabolic process (GO:0046487) | 2.95315025 |
| 127 | negative regulation of fibrinolysis (GO:0051918) | 2.94878798 |
| 128 | regulation of sequestering of triglyceride (GO:0010889) | 2.94313605 |
| 129 | 2-oxoglutarate metabolic process (GO:0006103) | 2.93030936 |
| 130 | S-adenosylmethionine metabolic process (GO:0046500) | 2.92531605 |
| 131 | regulation of skeletal muscle contraction (GO:0014819) | 2.91224336 |
| 132 | T cell selection (GO:0045058) | 2.90993000 |
| 133 | bile acid metabolic process (GO:0008206) | 2.90330244 |
| 134 | homocysteine metabolic process (GO:0050667) | 2.90269808 |
| 135 | protein-lipid complex remodeling (GO:0034368) | 2.89556313 |
| 136 | macromolecular complex remodeling (GO:0034367) | 2.89556313 |
| 137 | plasma lipoprotein particle remodeling (GO:0034369) | 2.89556313 |
| 138 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.89540211 |
| 139 | interferon-gamma production (GO:0032609) | 2.89493554 |
| 140 | alpha-amino acid catabolic process (GO:1901606) | 2.86831038 |
| 141 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.86329755 |
| 142 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.85535323 |
| 143 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.83426925 |
| 144 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.81884515 |
| 145 | sulfur amino acid catabolic process (GO:0000098) | 2.79103084 |
| 146 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.77620021 |
| 147 | NAD biosynthetic process (GO:0009435) | 2.77097923 |
| 148 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77060137 |
| 149 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.76464641 |
| 150 | positive regulation of fatty acid oxidation (GO:0046321) | 2.76346710 |
| 151 | carnitine metabolic process (GO:0009437) | 2.75374636 |
| 152 | cellular response to interleukin-15 (GO:0071350) | 2.75316085 |
| 153 | myeloid leukocyte activation (GO:0002274) | 2.75246488 |
| 154 | acylglycerol homeostasis (GO:0055090) | 2.74532454 |
| 155 | triglyceride homeostasis (GO:0070328) | 2.74532454 |
| 156 | response to protozoan (GO:0001562) | 2.73196404 |
| 157 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.72923064 |
| 158 | T-helper 1 type immune response (GO:0042088) | 2.70861284 |
| 159 | ketone body metabolic process (GO:1902224) | 2.70615426 |
| 160 | cholesterol efflux (GO:0033344) | 2.70039420 |
| 161 | arginine metabolic process (GO:0006525) | 2.68662888 |
| 162 | regulation of cholesterol esterification (GO:0010872) | 2.68508297 |
| 163 | cellular glucuronidation (GO:0052695) | 2.68231656 |
| 164 | short-chain fatty acid metabolic process (GO:0046459) | 2.68188824 |
| 165 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.67955322 |
| 166 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.66571414 |
| 167 | amine catabolic process (GO:0009310) | 2.66170112 |
| 168 | cellular biogenic amine catabolic process (GO:0042402) | 2.66170112 |
| 169 | negative regulation of B cell mediated immunity (GO:0002713) | 2.65780650 |
| 170 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.65780650 |
| 171 | negative regulation of B cell proliferation (GO:0030889) | 2.65041501 |
| 172 | quaternary ammonium group transport (GO:0015697) | 2.61895938 |
| 173 | iron ion import (GO:0097286) | 2.61372980 |
| 174 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.60391938 |
| 175 | complement activation, classical pathway (GO:0006958) | 2.58291266 |
| 176 | regulation of bile acid biosynthetic process (GO:0070857) | 2.57850382 |
| 177 | aromatic amino acid family metabolic process (GO:0009072) | 2.57648064 |
| 178 | plasma lipoprotein particle assembly (GO:0034377) | 2.57330242 |
| 179 | skeletal muscle adaptation (GO:0043501) | 2.57224091 |
| 180 | cellular amino acid catabolic process (GO:0009063) | 2.56917598 |
| 181 | complement activation (GO:0006956) | 2.56314269 |
| 182 | bile acid and bile salt transport (GO:0015721) | 2.55000703 |
| 183 | fatty acid beta-oxidation (GO:0006635) | 2.53010751 |
| 184 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.52869390 |
| 185 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.52869390 |
| 186 | protein targeting to Golgi (GO:0000042) | 2.52761289 |
| 187 | protein activation cascade (GO:0072376) | 2.52228117 |
| 188 | glycogen catabolic process (GO:0005980) | 2.51766456 |
| 189 | alkaloid metabolic process (GO:0009820) | 2.49188099 |
| 190 | carnitine transmembrane transport (GO:1902603) | 2.48428574 |
| 191 | fatty acid catabolic process (GO:0009062) | 2.47274147 |
| 192 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.47098239 |
| 193 | negative regulation of protein activation cascade (GO:2000258) | 2.46090812 |
| 194 | tyrosine metabolic process (GO:0006570) | 2.45557636 |
| 195 | urate metabolic process (GO:0046415) | 2.44894753 |
| 196 | cardiac muscle adaptation (GO:0014887) | 2.44546572 |
| 197 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.44546572 |
| 198 | muscle hypertrophy in response to stress (GO:0003299) | 2.44546572 |
| 199 | fatty acid oxidation (GO:0019395) | 2.44014126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.69209017 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.74416856 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.52222115 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.37002137 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.27189178 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.26840735 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.22756118 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.12585329 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.99323446 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.98684681 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.83916001 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61753467 |
| 13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.55338036 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.52588033 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.47898908 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.43275481 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.22068262 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.10429655 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.05480255 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.03926067 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.03876254 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 1.94134717 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 1.93179401 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91526737 |
| 25 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.87448414 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82458920 |
| 27 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.78097847 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.71374421 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.64643001 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.64004543 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63188461 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.61191181 |
| 33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.59014777 |
| 34 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55633545 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.54752496 |
| 36 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.52694208 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52286395 |
| 38 | GATA3_26560356_Chip-Seq_TH2_Human | 1.50704830 |
| 39 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.50196278 |
| 40 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.49246784 |
| 41 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45681409 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45599918 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44846553 |
| 44 | GATA1_19941826_ChIP-Seq_K562_Human | 1.43620747 |
| 45 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40970470 |
| 46 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39916597 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39009835 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38669371 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35461414 |
| 50 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.34783831 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33551244 |
| 52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.33049947 |
| 53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31300335 |
| 54 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.31080349 |
| 55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30777533 |
| 56 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.29890100 |
| 57 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28370822 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28008769 |
| 59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26327106 |
| 60 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.25097420 |
| 61 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22305148 |
| 62 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.22165305 |
| 63 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.21764100 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19002878 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18977456 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.18451915 |
| 67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18084769 |
| 68 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.15784498 |
| 69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15519678 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14686870 |
| 71 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.13941270 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13460409 |
| 73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13460409 |
| 74 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12335266 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.11871236 |
| 76 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.11827148 |
| 77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.11827148 |
| 78 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.11654450 |
| 79 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.10978911 |
| 80 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10859375 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09659055 |
| 82 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.09044293 |
| 83 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08828662 |
| 84 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08578768 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08247499 |
| 86 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07765494 |
| 87 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.07259038 |
| 88 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.06543051 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.06020289 |
| 90 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05785406 |
| 91 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05168841 |
| 92 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.04613690 |
| 93 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04501882 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04121406 |
| 95 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.03925742 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02449757 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02404669 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01392544 |
| 99 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01045786 |
| 100 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.00634965 |
| 101 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.00412283 |
| 102 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99047792 |
| 103 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97884063 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97462449 |
| 105 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97415470 |
| 106 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.96474838 |
| 107 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.96305170 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96209145 |
| 109 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.95707836 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95474326 |
| 111 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95467464 |
| 112 | * MYC_22102868_ChIP-Seq_BL_Human | 0.95019579 |
| 113 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94612772 |
| 114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94400760 |
| 115 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93051369 |
| 116 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.92209302 |
| 117 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91452785 |
| 118 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91123797 |
| 119 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90854805 |
| 120 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.90473888 |
| 121 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88312091 |
| 122 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87703113 |
| 123 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87579429 |
| 124 | P300_19829295_ChIP-Seq_ESCs_Human | 0.87077686 |
| 125 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.86823371 |
| 126 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.86681149 |
| 127 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.86229481 |
| 128 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86223473 |
| 129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86161265 |
| 130 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86151904 |
| 131 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.85437220 |
| 132 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84789163 |
| 133 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84733077 |
| 134 | MAF_26560356_Chip-Seq_TH2_Human | 0.83960473 |
| 135 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.83933733 |
| 136 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.83519033 |
| 137 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83373977 |
| 138 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.82895311 |
| 139 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.82895311 |
| 140 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.82878005 |
| 141 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82814458 |
| 142 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82723904 |
| 143 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.81673378 |
| 144 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.79589330 |
| 145 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.78610196 |
| 146 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78491408 |
| 147 | KDM2B_26808549_Chip-Seq_K562_Human | 0.77632437 |
| 148 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.77467863 |
| 149 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.77371555 |
| 150 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.76947721 |
| 151 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.76059497 |
| 152 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75631227 |
| 153 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.75539877 |
| 154 | TP53_16413492_ChIP-PET_HCT116_Human | 0.75343123 |
| 155 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.75258891 |
| 156 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75226784 |
| 157 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.75206017 |
| 158 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.74778759 |
| 159 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.72321394 |
| 160 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.71704410 |
| 161 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.70223842 |
| 162 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.69122355 |
| 163 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.69122355 |
| 164 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68427771 |
| 165 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.68343317 |
| 166 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.68277423 |
| 167 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.67523107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.14939763 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 4.48746463 |
| 3 | MP0005360_urolithiasis | 4.25866645 |
| 4 | MP0005365_abnormal_bile_salt | 3.89995193 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.41761265 |
| 6 | MP0003436_decreased_susceptibility_to | 3.33928109 |
| 7 | MP0002254_reproductive_system_inflammat | 2.92354631 |
| 8 | MP0005167_abnormal_blood-brain_barrier | 2.84381408 |
| 9 | MP0002419_abnormal_innate_immunity | 2.83463737 |
| 10 | MP0003646_muscle_fatigue | 2.75956174 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.75844689 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.75201308 |
| 13 | MP0005671_abnormal_response_to | 2.73718462 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.70947171 |
| 15 | MP0000685_abnormal_immune_system | 2.70122060 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.68207613 |
| 17 | MP0005387_immune_system_phenotype | 2.56823797 |
| 18 | MP0001790_abnormal_immune_system | 2.56823797 |
| 19 | MP0002723_abnormal_immune_serum | 2.53429317 |
| 20 | MP0004130_abnormal_muscle_cell | 2.53328271 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.51734667 |
| 22 | MP0005025_abnormal_response_to | 2.51289963 |
| 23 | MP0008260_abnormal_autophagy | 2.44979951 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.44110916 |
| 25 | MP0009785_altered_susceptibility_to | 2.41671153 |
| 26 | MP0003252_abnormal_bile_duct | 2.41215394 |
| 27 | MP0001819_abnormal_immune_cell | 2.40556726 |
| 28 | MP0003763_abnormal_thymus_physiology | 2.38540067 |
| 29 | MP0010368_abnormal_lymphatic_system | 2.35321476 |
| 30 | MP0004147_increased_porphyrin_level | 2.35128281 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 2.30613848 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 2.19158397 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 2.17686381 |
| 34 | MP0001879_abnormal_lymphatic_vessel | 2.10300168 |
| 35 | MP0002405_respiratory_system_inflammati | 2.07620963 |
| 36 | MP0004510_myositis | 2.06405781 |
| 37 | MP0005464_abnormal_platelet_physiology | 2.02616460 |
| 38 | MP0003300_gastrointestinal_ulcer | 2.00646268 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.97942691 |
| 40 | MP0009840_abnormal_foam_cell | 1.97763612 |
| 41 | MP0002398_abnormal_bone_marrow | 1.95631389 |
| 42 | MP0003806_abnormal_nucleotide_metabolis | 1.95096688 |
| 43 | MP0000716_abnormal_immune_system | 1.88327309 |
| 44 | MP0004484_altered_response_of | 1.83361104 |
| 45 | MP0006082_CNS_inflammation | 1.80577847 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.75340333 |
| 47 | MP0005332_abnormal_amino_acid | 1.75237345 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.74248398 |
| 49 | MP0004883_abnormal_blood_vessel | 1.71865600 |
| 50 | MP0005670_abnormal_white_adipose | 1.71252194 |
| 51 | MP0002009_preneoplasia | 1.67883469 |
| 52 | MP0005083_abnormal_biliary_tract | 1.67139043 |
| 53 | MP0004947_skin_inflammation | 1.66105809 |
| 54 | MP0004381_abnormal_hair_follicle | 1.64689165 |
| 55 | MP0004215_abnormal_myocardial_fiber | 1.64327704 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.63076741 |
| 57 | MP0001851_eye_inflammation | 1.60191526 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.59670136 |
| 59 | MP0002722_abnormal_immune_system | 1.59461987 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 1.58223764 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.57376208 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.53622593 |
| 63 | MP0000609_abnormal_liver_physiology | 1.52732695 |
| 64 | MP0005310_abnormal_salivary_gland | 1.52388820 |
| 65 | MP0006138_congestive_heart_failure | 1.51834426 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 1.48693281 |
| 67 | MP0002429_abnormal_blood_cell | 1.45364813 |
| 68 | MP0001545_abnormal_hematopoietic_system | 1.45206048 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 1.45206048 |
| 70 | MP0005084_abnormal_gallbladder_morpholo | 1.44065321 |
| 71 | MP0009278_abnormal_bone_marrow | 1.43705932 |
| 72 | MP0001666_abnormal_nutrient_absorption | 1.43599305 |
| 73 | MP0000703_abnormal_thymus_morphology | 1.42254309 |
| 74 | MP0004019_abnormal_vitamin_homeostasis | 1.39973367 |
| 75 | MP0002971_abnormal_brown_adipose | 1.38836482 |
| 76 | MP0002396_abnormal_hematopoietic_system | 1.35877216 |
| 77 | MP0004036_abnormal_muscle_relaxation | 1.34358091 |
| 78 | MP0004859_abnormal_synaptic_plasticity | 1.34346814 |
| 79 | MP0002822_catalepsy | 1.31429173 |
| 80 | MP0001873_stomach_inflammation | 1.31311808 |
| 81 | MP0003866_abnormal_defecation | 1.31074617 |
| 82 | MP0000751_myopathy | 1.30920497 |
| 83 | MP0005174_abnormal_tail_pigmentation | 1.29403086 |
| 84 | MP0005164_abnormal_response_to | 1.28686946 |
| 85 | MP0000015_abnormal_ear_pigmentation | 1.26641495 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 1.26594211 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 1.26237327 |
| 88 | MP0004145_abnormal_muscle_electrophysio | 1.24104154 |
| 89 | MP0009764_decreased_sensitivity_to | 1.20890406 |
| 90 | MP0005620_abnormal_muscle_contractility | 1.20524870 |
| 91 | MP0003195_calcinosis | 1.18624894 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.17943563 |
| 93 | MP0002166_altered_tumor_susceptibility | 1.16898144 |
| 94 | MP0001544_abnormal_cardiovascular_syste | 1.13987016 |
| 95 | MP0005385_cardiovascular_system_phenoty | 1.13987016 |
| 96 | MP0003868_abnormal_feces_composition | 1.13404990 |
| 97 | MP0002998_abnormal_bone_remodeling | 1.13227982 |
| 98 | MP0005535_abnormal_body_temperature | 1.10841555 |
| 99 | MP0002132_abnormal_respiratory_system | 1.08000694 |
| 100 | MP0005330_cardiomyopathy | 1.07770353 |
| 101 | MP0008057_abnormal_DNA_replication | 1.07342779 |
| 102 | MP0003724_increased_susceptibility_to | 1.07020307 |
| 103 | MP0004087_abnormal_muscle_fiber | 1.05688010 |
| 104 | MP0005451_abnormal_body_composition | 1.05160399 |
| 105 | MP0010630_abnormal_cardiac_muscle | 1.04676008 |
| 106 | MP0009333_abnormal_splenocyte_physiolog | 1.04222685 |
| 107 | MP0000858_altered_metastatic_potential | 1.01298588 |
| 108 | MP0000749_muscle_degeneration | 1.00370258 |
| 109 | MP0004808_abnormal_hematopoietic_stem | 1.00362291 |
| 110 | MP0008004_abnormal_stomach_pH | 0.97962322 |
| 111 | MP0002106_abnormal_muscle_physiology | 0.97823866 |
| 112 | MP0002277_abnormal_respiratory_mucosa | 0.96689700 |
| 113 | MP0003091_abnormal_cell_migration | 0.95431405 |
| 114 | MP0003690_abnormal_glial_cell | 0.94845092 |
| 115 | MP0002972_abnormal_cardiac_muscle | 0.91910446 |
| 116 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90323290 |
| 117 | MP0002928_abnormal_bile_duct | 0.89781537 |
| 118 | MP0000604_amyloidosis | 0.88475378 |
| 119 | MP0003633_abnormal_nervous_system | 0.84135494 |
| 120 | MP0003879_abnormal_hair_cell | 0.84054704 |
| 121 | MP0005369_muscle_phenotype | 0.83896302 |
| 122 | MP0006035_abnormal_mitochondrial_morpho | 0.83869613 |
| 123 | MP0001764_abnormal_homeostasis | 0.83853283 |
| 124 | MP0005334_abnormal_fat_pad | 0.83729737 |
| 125 | MP0009765_abnormal_xenobiotic_induced | 0.83474382 |
| 126 | MP0001501_abnormal_sleep_pattern | 0.82979897 |
| 127 | MP0000371_diluted_coat_color | 0.82282602 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.81294655 |
| 129 | MP0009697_abnormal_copulation | 0.80817898 |
| 130 | MP0008995_early_reproductive_senescence | 0.80654597 |
| 131 | MP0006036_abnormal_mitochondrial_physio | 0.80643784 |
| 132 | MP0002269_muscular_atrophy | 0.78262315 |
| 133 | MP0001835_abnormal_antigen_presentation | 0.78146334 |
| 134 | MP0002876_abnormal_thyroid_physiology | 0.78032562 |
| 135 | MP0002006_tumorigenesis | 0.77935327 |
| 136 | MP0000343_altered_response_to | 0.77521611 |
| 137 | MP0005388_respiratory_system_phenotype | 0.76546451 |
| 138 | MP0002133_abnormal_respiratory_system | 0.76546451 |
| 139 | MP0005666_abnormal_adipose_tissue | 0.76142486 |
| 140 | MP0004084_abnormal_cardiac_muscle | 0.75949788 |
| 141 | MP0003635_abnormal_synaptic_transmissio | 0.75301034 |
| 142 | MP0003045_fibrosis | 0.75078575 |
| 143 | MP0003787_abnormal_imprinting | 0.74768035 |
| 144 | MP0003828_pulmonary_edema | 0.74160223 |
| 145 | MP0000598_abnormal_liver_morphology | 0.73927166 |
| 146 | MP0002078_abnormal_glucose_homeostasis | 0.73777642 |
| 147 | MP0000747_muscle_weakness | 0.72998147 |
| 148 | MP0002127_abnormal_cardiovascular_syste | 0.71928662 |
| 149 | MP0001663_abnormal_digestive_system | 0.71267070 |
| 150 | MP0009763_increased_sensitivity_to | 0.70870282 |
| 151 | MP0003631_nervous_system_phenotype | 0.70800166 |
| 152 | MP0000230_abnormal_systemic_arterial | 0.70238771 |
| 153 | MP0003448_altered_tumor_morphology | 0.69375110 |
| 154 | MP0005647_abnormal_sex_gland | 0.68702316 |
| 155 | MP0005058_abnormal_lysosome_morphology | 0.68698978 |
| 156 | MP0004085_abnormal_heartbeat | 0.68219385 |
| 157 | MP0003303_peritoneal_inflammation | 0.67348746 |
| 158 | MP0008961_abnormal_basal_metabolism | 0.66736530 |
| 159 | MP0000249_abnormal_blood_vessel | 0.66671955 |
| 160 | MP0009115_abnormal_fat_cell | 0.65354467 |
| 161 | MP0003075_altered_response_to | 0.65347138 |
| 162 | MP0005165_increased_susceptibility_to | 0.64889161 |
| 163 | MP0001853_heart_inflammation | 0.64108231 |
| 164 | MP0000759_abnormal_skeletal_muscle | 0.63391992 |
| 165 | MP0008874_decreased_physiological_sensi | 0.62784374 |
| 166 | MP0009046_muscle_twitch | 0.62139389 |
| 167 | MP0008469_abnormal_protein_level | 0.61519251 |
| 168 | MP0001800_abnormal_humoral_immune | 0.61385001 |
| 169 | MP0005166_decreased_susceptibility_to | 0.60758861 |
| 170 | MP0004270_analgesia | 0.60275495 |
| 171 | MP0001986_abnormal_taste_sensitivity | 0.58621596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.62587670 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.49215853 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.98653944 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 4.74853187 |
| 5 | Optic neuritis (HP:0100653) | 4.74853187 |
| 6 | Myositis (HP:0100614) | 4.65206134 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.57482366 |
| 8 | Stomatitis (HP:0010280) | 4.50634599 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.46239587 |
| 10 | Orchitis (HP:0100796) | 4.45055408 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.35754897 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.32133426 |
| 13 | Hypochromic microcytic anemia (HP:0004840) | 4.31890612 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 4.21987104 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.12128181 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 4.05392714 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.95942564 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.92677279 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.92677279 |
| 20 | Recurrent skin infections (HP:0001581) | 3.84954618 |
| 21 | Xanthomatosis (HP:0000991) | 3.80775128 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 3.80335535 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.79846100 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 3.79689977 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.77376862 |
| 26 | T lymphocytopenia (HP:0005403) | 3.76917988 |
| 27 | Facial diplegia (HP:0001349) | 3.72215916 |
| 28 | Keratoconjunctivitis sicca (HP:0001097) | 3.65458933 |
| 29 | Abnormality of T cell number (HP:0011839) | 3.61652728 |
| 30 | Meningitis (HP:0001287) | 3.56915179 |
| 31 | Exercise-induced myalgia (HP:0003738) | 3.54628295 |
| 32 | Vasculitis (HP:0002633) | 3.53026708 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.52950689 |
| 34 | Complement deficiency (HP:0004431) | 3.52898278 |
| 35 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.41816088 |
| 36 | Keratoconjunctivitis (HP:0001096) | 3.39452582 |
| 37 | Hypolipoproteinemia (HP:0010981) | 3.38759430 |
| 38 | Hypobetalipoproteinemia (HP:0003563) | 3.36921740 |
| 39 | Epidermoid cyst (HP:0200040) | 3.35866774 |
| 40 | Encephalitis (HP:0002383) | 3.34651707 |
| 41 | Joint hemorrhage (HP:0005261) | 3.33142375 |
| 42 | Spontaneous hematomas (HP:0007420) | 3.31440834 |
| 43 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.25237166 |
| 44 | Recurrent viral infections (HP:0004429) | 3.21885970 |
| 45 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.11809117 |
| 46 | Hemoptysis (HP:0002105) | 3.10842843 |
| 47 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.09184293 |
| 48 | Pulmonary infiltrates (HP:0002113) | 3.06406455 |
| 49 | Obstructive lung disease (HP:0006536) | 3.03195889 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 3.03195889 |
| 51 | Prolonged bleeding time (HP:0003010) | 3.01653220 |
| 52 | Leukocytosis (HP:0001974) | 2.99473600 |
| 53 | Hyperammonemia (HP:0001987) | 2.99288960 |
| 54 | Gingivitis (HP:0000230) | 2.98601489 |
| 55 | Progressive inability to walk (HP:0002505) | 2.96338194 |
| 56 | Chest pain (HP:0100749) | 2.95667914 |
| 57 | Poikilocytosis (HP:0004447) | 2.93889645 |
| 58 | Polycythemia (HP:0001901) | 2.91830901 |
| 59 | Ketosis (HP:0001946) | 2.90126049 |
| 60 | Gingival bleeding (HP:0000225) | 2.88234501 |
| 61 | Abnormality of T cells (HP:0002843) | 2.88023647 |
| 62 | Cholelithiasis (HP:0001081) | 2.86723280 |
| 63 | Panhypogammaglobulinemia (HP:0003139) | 2.85219880 |
| 64 | Urticaria (HP:0001025) | 2.85202523 |
| 65 | Arterial thrombosis (HP:0004420) | 2.81793247 |
| 66 | Myoglobinuria (HP:0002913) | 2.80046383 |
| 67 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.77873390 |
| 68 | Hyperglycinuria (HP:0003108) | 2.76687231 |
| 69 | Abnormality of the common coagulation pathway (HP:0010990) | 2.75848319 |
| 70 | Myocardial infarction (HP:0001658) | 2.73465757 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.70241040 |
| 72 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.68738268 |
| 73 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.67538641 |
| 74 | Abnormal gallbladder morphology (HP:0012437) | 2.63730033 |
| 75 | Viral hepatitis (HP:0006562) | 2.62496026 |
| 76 | Esophageal varix (HP:0002040) | 2.62127271 |
| 77 | Calf muscle hypertrophy (HP:0008981) | 2.61657592 |
| 78 | Hyperglycinemia (HP:0002154) | 2.61051299 |
| 79 | Hyperbilirubinemia (HP:0002904) | 2.59448007 |
| 80 | Epistaxis (HP:0000421) | 2.58930854 |
| 81 | Cellulitis (HP:0100658) | 2.57318083 |
| 82 | Autoimmune hemolytic anemia (HP:0001890) | 2.55970898 |
| 83 | Hypoglycemic seizures (HP:0002173) | 2.51964684 |
| 84 | Recurrent bronchitis (HP:0002837) | 2.49323573 |
| 85 | Pustule (HP:0200039) | 2.48695948 |
| 86 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.48468215 |
| 87 | Hypercholesterolemia (HP:0003124) | 2.46965310 |
| 88 | Gangrene (HP:0100758) | 2.45512189 |
| 89 | Abnormality of glycine metabolism (HP:0010895) | 2.44516769 |
| 90 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.44516769 |
| 91 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.44379432 |
| 92 | Gastrointestinal inflammation (HP:0004386) | 2.44094386 |
| 93 | Pulmonary embolism (HP:0002204) | 2.43881527 |
| 94 | Acanthocytosis (HP:0001927) | 2.43196529 |
| 95 | Agammaglobulinemia (HP:0004432) | 2.39168869 |
| 96 | Osteomyelitis (HP:0002754) | 2.38252140 |
| 97 | Atrioventricular block (HP:0001678) | 2.37339986 |
| 98 | Stomach cancer (HP:0012126) | 2.36947889 |
| 99 | Papilledema (HP:0001085) | 2.36908663 |
| 100 | Eosinophilia (HP:0001880) | 2.36491590 |
| 101 | Spontaneous abortion (HP:0005268) | 2.35574997 |
| 102 | Abnormality of T cell physiology (HP:0011840) | 2.35259536 |
| 103 | Slow saccadic eye movements (HP:0000514) | 2.34761514 |
| 104 | Granulocytopenia (HP:0001913) | 2.33463219 |
| 105 | Subacute progressive viral hepatitis (HP:0006572) | 2.32160207 |
| 106 | Alveolar cell carcinoma (HP:0006519) | 2.31567742 |
| 107 | Amyloidosis (HP:0011034) | 2.31263071 |
| 108 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.31050977 |
| 109 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.29345304 |
| 110 | Increased IgE level (HP:0003212) | 2.28696228 |
| 111 | Skin nodule (HP:0200036) | 2.28093993 |
| 112 | Abnormality of the pleura (HP:0002103) | 2.26720242 |
| 113 | Muscle fiber inclusion bodies (HP:0100299) | 2.23465139 |
| 114 | Lymphopenia (HP:0001888) | 2.22959055 |
| 115 | Recurrent sinusitis (HP:0011108) | 2.22393282 |
| 116 | Ketoacidosis (HP:0001993) | 2.21942854 |
| 117 | Fat malabsorption (HP:0002630) | 2.20313061 |
| 118 | Abnormality of methionine metabolism (HP:0010901) | 2.20028302 |
| 119 | Abnormality of the fingertips (HP:0001211) | 2.19706246 |
| 120 | Inability to walk (HP:0002540) | 2.19569162 |
| 121 | Abnormality of complement system (HP:0005339) | 2.19499933 |
| 122 | Sudden death (HP:0001699) | 2.18843242 |
| 123 | Rhabdomyolysis (HP:0003201) | 2.18011663 |
| 124 | Paralysis (HP:0003470) | 2.17362835 |
| 125 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.17347322 |
| 126 | Reticulocytosis (HP:0001923) | 2.16862140 |
| 127 | Hematochezia (HP:0002573) | 2.16834574 |
| 128 | Abnormality of purine metabolism (HP:0004352) | 2.16208515 |
| 129 | IgM deficiency (HP:0002850) | 2.15941155 |
| 130 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.15302676 |
| 131 | Anorexia (HP:0002039) | 2.14474468 |
| 132 | Abnormality of the intrinsic pathway (HP:0010989) | 2.13661158 |
| 133 | Abnormality of eosinophils (HP:0001879) | 2.12723525 |
| 134 | Hyperventilation (HP:0002883) | 2.12549187 |
| 135 | Muscle stiffness (HP:0003552) | 2.12146370 |
| 136 | EMG: myopathic abnormalities (HP:0003458) | 2.11828019 |
| 137 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.11511429 |
| 138 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.10492285 |
| 139 | Subaortic stenosis (HP:0001682) | 2.10492285 |
| 140 | Hyperglycemia (HP:0003074) | 2.10268929 |
| 141 | Confusion (HP:0001289) | 2.09541744 |
| 142 | Gout (HP:0001997) | 2.09227450 |
| 143 | Keratitis (HP:0000491) | 2.08369216 |
| 144 | Episodic fever (HP:0001954) | 2.07135901 |
| 145 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.05372855 |
| 146 | Systemic lupus erythematosus (HP:0002725) | 2.04565104 |
| 147 | Autoimmune thrombocytopenia (HP:0001973) | 2.04257694 |
| 148 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.04000985 |
| 149 | Colitis (HP:0002583) | 2.02872497 |
| 150 | Heart block (HP:0012722) | 2.00649919 |
| 151 | Vertigo (HP:0002321) | 1.98837339 |
| 152 | Tetraparesis (HP:0002273) | 1.98565570 |
| 153 | Hemiplegia (HP:0002301) | 1.98183066 |
| 154 | Sepsis (HP:0100806) | 1.97932402 |
| 155 | Hepatocellular carcinoma (HP:0001402) | 1.97504483 |
| 156 | Interstitial pulmonary disease (HP:0006530) | 1.95829229 |
| 157 | Focal motor seizures (HP:0011153) | 1.95362091 |
| 158 | Vascular calcification (HP:0004934) | 1.95218563 |
| 159 | Status epilepticus (HP:0002133) | 1.94826359 |
| 160 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.93950763 |
| 161 | Metabolic acidosis (HP:0001942) | 1.93567303 |
| 162 | Fatigue (HP:0012378) | 1.93476724 |
| 163 | Abnormality of the prostate (HP:0008775) | 1.92822916 |
| 164 | Increased IgM level (HP:0003496) | 1.92364197 |
| 165 | Restrictive lung disease (HP:0002091) | 1.91730699 |
| 166 | Chronic diarrhea (HP:0002028) | 1.91629220 |
| 167 | Mitral stenosis (HP:0001718) | 1.90084738 |
| 168 | Sensorimotor neuropathy (HP:0007141) | 1.89824047 |
| 169 | Polyneuropathy (HP:0001271) | 1.89727786 |
| 170 | Muscle fiber splitting (HP:0003555) | 1.89237134 |
| 171 | Difficulty running (HP:0009046) | 1.89058304 |
| 172 | Bundle branch block (HP:0011710) | 1.87666671 |
| 173 | Abnormality of nucleobase metabolism (HP:0010932) | 1.87627679 |
| 174 | Amaurosis fugax (HP:0100576) | 1.86436713 |
| 175 | Microcytic anemia (HP:0001935) | 1.86308752 |
| 176 | Syncope (HP:0001279) | 1.86200111 |
| 177 | Hypochromic anemia (HP:0001931) | 1.86074237 |
| 178 | Glomerulopathy (HP:0100820) | 1.85401887 |
| 179 | Dysmetric saccades (HP:0000641) | 1.84624045 |
| 180 | Annular pancreas (HP:0001734) | 1.84493591 |
| 181 | Abnormality of serum amino acid levels (HP:0003112) | 1.84392203 |
| 182 | Abnormality of the peritoneum (HP:0002585) | 1.83816544 |
| 183 | Increased CSF protein (HP:0002922) | 1.83631296 |
| 184 | Delayed CNS myelination (HP:0002188) | 1.82529611 |
| 185 | Peritonitis (HP:0002586) | 1.82510194 |
| 186 | Drooling (HP:0002307) | 1.82153668 |
| 187 | Excessive salivation (HP:0003781) | 1.82153668 |
| 188 | Hyperkalemia (HP:0002153) | 1.81899131 |
| 189 | Gastrointestinal stroma tumor (HP:0100723) | 1.81609127 |
| 190 | Fair hair (HP:0002286) | 1.81583317 |
| 191 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.81572622 |
| 192 | Abnormality of the endocardium (HP:0004306) | 1.81554157 |
| 193 | IgG deficiency (HP:0004315) | 1.81053894 |
| 194 | Verrucae (HP:0200043) | 1.80332022 |
| 195 | Papilloma (HP:0012740) | 1.80332022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 9.01066893 |
| 2 | BLK | 3.29248436 |
| 3 | GRK1 | 2.54184735 |
| 4 | IRAK4 | 2.54012119 |
| 5 | TXK | 2.07681286 |
| 6 | PRPF4B | 2.05163990 |
| 7 | OBSCN | 1.98137634 |
| 8 | PHKG2 | 1.97960687 |
| 9 | PHKG1 | 1.97960687 |
| 10 | CAMK1D | 1.89377873 |
| 11 | FGR | 1.86066412 |
| 12 | PRKAA2 | 1.81834197 |
| 13 | ZAP70 | 1.81557315 |
| 14 | MAP3K14 | 1.80251508 |
| 15 | BTK | 1.79643523 |
| 16 | CAMK1G | 1.76764632 |
| 17 | INSRR | 1.71388468 |
| 18 | MAP2K4 | 1.70647644 |
| 19 | MAP3K7 | 1.70130604 |
| 20 | IRAK1 | 1.68337585 |
| 21 | EPHA4 | 1.64090470 |
| 22 | TEC | 1.62888548 |
| 23 | JAK3 | 1.60781586 |
| 24 | TTN | 1.58205614 |
| 25 | RIPK4 | 1.54060709 |
| 26 | MAPK12 | 1.53583968 |
| 27 | MAP3K13 | 1.52656649 |
| 28 | HCK | 1.49509182 |
| 29 | SGK2 | 1.46709367 |
| 30 | PINK1 | 1.43898921 |
| 31 | AKT3 | 1.43379123 |
| 32 | SGK3 | 1.40122716 |
| 33 | LYN | 1.35305397 |
| 34 | ITK | 1.35096709 |
| 35 | MARK3 | 1.34635029 |
| 36 | PIK3CA | 1.33255612 |
| 37 | FGFR3 | 1.29766658 |
| 38 | BMX | 1.29179252 |
| 39 | MAPK7 | 1.27466483 |
| 40 | MAP3K12 | 1.26126089 |
| 41 | MAPK15 | 1.23309137 |
| 42 | KDR | 1.23253784 |
| 43 | JAK1 | 1.23227481 |
| 44 | CSF1R | 1.23174170 |
| 45 | PIK3CG | 1.21850505 |
| 46 | EPHB1 | 1.21674193 |
| 47 | KIT | 1.20618136 |
| 48 | BCKDK | 1.19582400 |
| 49 | YES1 | 1.15249059 |
| 50 | TGFBR2 | 1.15033613 |
| 51 | MAP3K6 | 1.14613617 |
| 52 | PRKAA1 | 1.14100107 |
| 53 | IRAK2 | 1.13007086 |
| 54 | MATK | 1.12188746 |
| 55 | TYK2 | 1.09634078 |
| 56 | LCK | 1.09357894 |
| 57 | FGFR4 | 1.07633219 |
| 58 | SIK3 | 1.03954822 |
| 59 | PAK3 | 1.03769112 |
| 60 | TNIK | 1.00035980 |
| 61 | MAP3K1 | 0.96579143 |
| 62 | PIM1 | 0.92630746 |
| 63 | MAP2K3 | 0.92156718 |
| 64 | TNK2 | 0.89505148 |
| 65 | NTRK3 | 0.87489681 |
| 66 | PDPK1 | 0.86914553 |
| 67 | PTK2B | 0.86063395 |
| 68 | MARK2 | 0.85898923 |
| 69 | SIK1 | 0.83864988 |
| 70 | KSR1 | 0.83187128 |
| 71 | JAK2 | 0.79773147 |
| 72 | BRD4 | 0.79283822 |
| 73 | WNK1 | 0.78665457 |
| 74 | SGK1 | 0.78258502 |
| 75 | CAMK4 | 0.74568671 |
| 76 | IKBKE | 0.73101417 |
| 77 | SGK223 | 0.72806760 |
| 78 | SGK494 | 0.72806760 |
| 79 | ACVR1B | 0.72182982 |
| 80 | TBK1 | 0.71055857 |
| 81 | MAPK11 | 0.70197678 |
| 82 | KSR2 | 0.69488686 |
| 83 | MAP3K5 | 0.69452065 |
| 84 | MARK1 | 0.69203813 |
| 85 | PDK1 | 0.68861140 |
| 86 | PRKCE | 0.68016377 |
| 87 | STK10 | 0.67104458 |
| 88 | PRKCG | 0.66935476 |
| 89 | MAP3K2 | 0.66762482 |
| 90 | IKBKB | 0.65948540 |
| 91 | NLK | 0.65627669 |
| 92 | MAPK4 | 0.64033762 |
| 93 | MAP3K4 | 0.62703188 |
| 94 | MAP2K1 | 0.61713142 |
| 95 | DAPK2 | 0.61612263 |
| 96 | RET | 0.61581651 |
| 97 | CAMKK2 | 0.60295920 |
| 98 | GRK6 | 0.59763463 |
| 99 | STK24 | 0.59522187 |
| 100 | NEK9 | 0.58038536 |
| 101 | GRK7 | 0.57710823 |
| 102 | BMPR2 | 0.56965290 |
| 103 | PTK6 | 0.56675023 |
| 104 | CHUK | 0.55612690 |
| 105 | PKN1 | 0.54908714 |
| 106 | CAMK1 | 0.54865049 |
| 107 | TAOK1 | 0.54445929 |
| 108 | MAP3K9 | 0.53765436 |
| 109 | PRKCQ | 0.53500855 |
| 110 | DYRK3 | 0.53342154 |
| 111 | CAMKK1 | 0.52860336 |
| 112 | ZAK | 0.52541797 |
| 113 | PRKCH | 0.52428353 |
| 114 | IRAK3 | 0.52216026 |
| 115 | MAP4K1 | 0.50629473 |
| 116 | FYN | 0.50167164 |
| 117 | DYRK1A | 0.50028151 |
| 118 | SIK2 | 0.49372810 |
| 119 | TAOK3 | 0.49081986 |
| 120 | MAP2K2 | 0.49075021 |
| 121 | ERBB2 | 0.48412008 |
| 122 | PRKCZ | 0.47813156 |
| 123 | HIPK2 | 0.47272405 |
| 124 | EPHA3 | 0.47175640 |
| 125 | MYLK | 0.47019051 |
| 126 | LMTK2 | 0.45266840 |
| 127 | PRKD1 | 0.45215025 |
| 128 | PDK2 | 0.45056826 |
| 129 | PDK4 | 0.43858696 |
| 130 | PDK3 | 0.43858696 |
| 131 | FES | 0.43742314 |
| 132 | PRKACG | 0.43649718 |
| 133 | EGFR | 0.42733182 |
| 134 | SYK | 0.41871201 |
| 135 | LRRK2 | 0.41807769 |
| 136 | CDK6 | 0.41676983 |
| 137 | TRPM7 | 0.41353915 |
| 138 | CDC42BPA | 0.41014972 |
| 139 | MAP3K11 | 0.40337764 |
| 140 | CSK | 0.40182563 |
| 141 | DYRK1B | 0.40051871 |
| 142 | MAP3K3 | 0.38990757 |
| 143 | MELK | 0.38152412 |
| 144 | RPS6KA3 | 0.37334388 |
| 145 | NEK6 | 0.36620177 |
| 146 | STK11 | 0.36490415 |
| 147 | CDK19 | 0.35605486 |
| 148 | FRK | 0.34088990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.95846242 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.60008003 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.32493182 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.88175410 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.83352016 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.27828777 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.24047924 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16154410 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.14406754 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.13461921 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.08789622 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.03472703 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 2.03000426 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.00344356 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.97722998 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.94896687 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.91091321 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.90362320 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.86266649 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.85544107 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.84151585 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83836782 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.83206283 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.78352752 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76121222 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.74363075 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.70676706 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65960183 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.65944504 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.65359286 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.63145485 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.62980298 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.62188852 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.61955473 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.58931355 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58399312 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.54563469 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.51598810 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.51049600 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49357913 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.49229612 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.47126341 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44746991 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.43077752 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.42171665 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40643753 |
| 47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39711609 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.37483231 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.36202090 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35249226 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34632722 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29565946 |
| 53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.25614172 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24863863 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 1.23604056 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21662421 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.21140780 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21053049 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20751549 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19422502 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.18575087 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 1.18251786 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.16977325 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 1.12856599 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11346365 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.11006254 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.09865040 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.09802444 |
| 69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.07720926 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 1.07578994 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06330129 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06132929 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.04370126 |
| 74 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03876957 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02064937 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99795868 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.99652326 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99503567 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.96376434 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96039206 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92504923 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92273501 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91758569 |
| 84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.89626496 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89106027 |
| 86 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87086997 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.87034364 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.85519626 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85238749 |
| 90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84810766 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.84659910 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83072335 |
| 93 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82882864 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82182836 |
| 95 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78419331 |
| 96 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77753998 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77687227 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76358539 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76331801 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75522868 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74637204 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74583958 |
| 103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74405550 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73648250 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73541580 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.71141612 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71041795 |
| 108 | GABAergic synapse_Homo sapiens_hsa04727 | 0.71028565 |
| 109 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.70748997 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70685164 |
| 111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70513116 |
| 112 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68725179 |
| 113 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66912801 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66353540 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.66173231 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65579332 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64944688 |
| 118 | Shigellosis_Homo sapiens_hsa05131 | 0.64658609 |
| 119 | Morphine addiction_Homo sapiens_hsa05032 | 0.64507337 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62959941 |
| 121 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62672840 |
| 122 | Circadian entrainment_Homo sapiens_hsa04713 | 0.62015962 |
| 123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61968647 |
| 124 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.61643881 |
| 125 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60852051 |
| 126 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.59407461 |
| 127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58605596 |
| 128 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58465776 |
| 129 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58356612 |
| 130 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.57731113 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57154582 |
| 132 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56519644 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56217766 |
| 134 | Prostate cancer_Homo sapiens_hsa05215 | 0.55524778 |
| 135 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55411421 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54872320 |
| 137 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54572892 |
| 138 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54019118 |
| 139 | Lysosome_Homo sapiens_hsa04142 | 0.53931180 |
| 140 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.53697093 |
| 141 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52285932 |
| 142 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51622302 |
| 143 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51199782 |
| 144 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49929593 |
| 145 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49880852 |
| 146 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49516966 |
| 147 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48135899 |
| 148 | Lysine degradation_Homo sapiens_hsa00310 | 0.47886231 |
| 149 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.47722152 |
| 150 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.47626115 |
| 151 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47487807 |
| 152 | Renin secretion_Homo sapiens_hsa04924 | 0.46989369 |
| 153 | Amoebiasis_Homo sapiens_hsa05146 | 0.46818378 |
| 154 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.45471697 |
| 155 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44916589 |
| 156 | Salivary secretion_Homo sapiens_hsa04970 | 0.44176536 |
| 157 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42904587 |
| 158 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.42875021 |
| 159 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41230273 |
| 160 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40704391 |
| 161 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40594648 |
| 162 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.40448251 |
| 163 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.40339119 |
| 164 | Glioma_Homo sapiens_hsa05214 | 0.40256021 |
| 165 | Endocytosis_Homo sapiens_hsa04144 | 0.40092102 |
| 166 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.38860339 |
| 167 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38518222 |
| 168 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38088281 |
| 169 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37880307 |
| 170 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36443153 |
| 171 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35583435 |
| 172 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35219164 |
| 173 | Long-term potentiation_Homo sapiens_hsa04720 | 0.34780144 |
| 174 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34168153 |
| 175 | Taste transduction_Homo sapiens_hsa04742 | 0.33059843 |
| 176 | Insulin secretion_Homo sapiens_hsa04911 | 0.32574764 |
| 177 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31247396 |
| 178 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30803134 |
| 179 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30301557 |
| 180 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28067788 |
| 181 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.27653662 |

